Where is KLAS located?

KLAS is headquartered in Orem, United States. It is registered at Rēzekne, Varoņu iela 25/2.

Who is the current CEO of KLAS?

Adam Gale of KLAS. They have also founded 1 company.

How many employees does KLAS have?

As of Aug 31, 2026, the latest employee count at KLAS is 293.

Where does KLAS rank among its competitors?

KLAS ranks 4th amongst 51 active competitors, of which 8 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Navidence, which secured an undisclosed amount in May, 2026.

Who are the top competitors of KLAS?

KLAS's top competitors include ESO, Sanguine and MDI. Among them, Navidence secured the most recent funding round in May, 2026.

KLAS - 2026 Company Profile, Team & Competitors

KLAS is an unfunded company based in Orem (United States), founded in 1996 by Scott Holbrook, Adam Gale, Kent Gale and Leonard Black. It operates as a Healthcare data reports and insights provider. KLAS has not raised any funding yet. The company has 51 active competitors, including 8 funded and 5 that have exited. Its top competitors include companies like ESO, Sanguine and MDI.

Company Details

KLAS offers healthcare data reports and insights. It allows users to collect healthcare data, analyze and capture insights from the data, provide market reports and share with vendors, partners, and clients. It enables users to manage trends, data research solutions, and services related to performance reviews. It provides data related to inpatient clinical data, ambulance, and post-acute care, and financial revenue data.

Website: engage.klasresearch.com
Social
Email ID: *****@klasresearch.com
Registered Address: Rēzekne, Varoņu iela 25/2

Key Metrics

Founded Year

1996

Location

Orem, United States

Stage

Unfunded

Ranked

4^th among 51 active competitors

Employee Count

293 as on Aug 31, 2026

Similar Companies

ESO & 69 more

View KLAS's full profile

KLAS is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
KLAS O CIN: 42402004759 , Latvia, Active	Aug 22, 1995	€0 - €1M (As on Dec 31, 2024)	12 (As on Dec 31, 2022)	-

KLAS has not raised any funding rounds yet.

The founders of KLAS are Scott Holbrook, Adam Gale, Kent Gale and Leonard Black. Adam Gale is the CEO of KLAS.

Here are the details of KLAS's key team members:

Scott Holbrook: Co-Founder of KLAS and founder of 1 other company.
Adam Gale: Co-Founder & CEO of KLAS and founder of 1 other company.
Contact Info: 1 phone number
Kent Gale: Founder of KLAS and founder of 1 other company.
Leonard Black: Co-Founder of KLAS and founder of 1 other company.

View details of KLAS's Founder profiles and Board Members

KLAS's employee count trend

KLAS has 293 employees as of Aug 26. Here is KLAS's employee count trend over the years:

Uncover KLAS's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of KLAS include ESO, Sanguine and MDI. Here is the list of Top 10 competitors of KLAS, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ESO 2004, Austin (United States), Series B	Provider of integrated software for emergency medical services	$50.4M	Austin Ventures, Golub Growth & 4 others	61/100
2nd	Sanguine 2010, Los Angeles (United States), Series B	Building a databank of patient-derived data for advanced research	$5.53M	Broadoak Capital Partners, FCVC & 9 others	55/100
3rd	MDI 2018, Seattle (United States), Series A	AI-based medication management tool for healthcare professionals	$27M	Hanaco Ventures, Intel Capital & 7 others	48/100
4th	KLAS 1996, Orem (United States), Unfunded	Healthcare data reports and insights provider	-	-	45/100
5th	Symphony Health 2012, Horsham (United States), Acquired	Provider of clinical research, consulting, and commercial services for healthcare sectors	-	Autonomy Ventures, STG	42/100
6th	Collaborative Drug Discovery 2004, Burlingame (United States), Series A	Biological and chemical database to manage private and external data	-	Lilly, Gates & 4 others	39/100
7th	Searchlight Health 2007, Bengaluru (India), Series A	Healthcare data analytics and business intelligence solutions	$4.6M	Greylock Partners, Piramal Group & 4 others	35/100
8th	Navidence 2025, United States, Seed	Provider of real-world evidence study design and real-world data assessment	$3.02M	Grand Ventures, Nina Capital & 1 others	35/100
9th	Amplion 2013, Bend (United States), Series A	Provider of software solutions for biotech, pharma, and academia	$1.02M	Seven Peaks Ventures, Greycroft & 11 others	34/100
10th	Reaction Data 2012, American Fork (United States), Seed	Healthcare experience management platform for customer, employee, and market insights	$750K	Frazier VC, Kickstart Fund & 1 others	34/100